Evaluation of phenolic profile, antioxidant and anticancer potential of two main representants of Zingiberaceae family against B164A5 murine melanoma cells

Biological Research

Volumn 48, Issue , 2015, Pages

  Danciu, Corina ^a   Vlaia, Lavinia ^a   Fetea, Florinela ^b   Hancianu, Monica ^c   Coricovac, Dorina E ^a   Ciurlea, Sorina A ^a   Şoica, Codruţa M ^a   Marincu, Iosif ^a   Vlaia, Vicentiu ^a   Dehelean, Cristina A ^c   Trandafirescu, Cristina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Antioxidant; Curcuma longa linnaeus; Melanoma; Polyphenols; Zingiber officinale roscoe

Indexed keywords

CURCUMA; CURCUMA LONGA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; ZINGIBER; ZINGIBER OFFICINALE; ZINGIBERACEAE;

ANTINEOPLASTIC AGENT; ANTIOXIDANT; PLANT EXTRACT; POLYPHENOL;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; CLASSIFICATION; CURCUMA; DRUG EFFECTS; GINGER; ISOLATION AND PURIFICATION; MELANOMA, EXPERIMENTAL; RHIZOME; TUMOR CELL LINE; ZINGIBERACEAE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMA; GINGER; MELANOMA, EXPERIMENTAL; PLANT EXTRACTS; POLYPHENOLS; RHIZOME; ZINGIBERACEAE;

EID: 84930159473     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.1186/0717-6287-48-1     Document Type: Article

References (77)

1. Kress WJ, Prince LM, Williams KJ. The phylogeny and a new classification of the gingers (Zingiberaceae): evidence from molecular data. Am J Bot. 2002;89:1682–96.
2. Tushar, Basak S, Sarma GC, Rangan L. Ethnomedical uses of Zingiberaceous plants of Northeast India. J Ethnopharmacol. 2010;132:286–96.
3. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003;9:161–8.
4. Araújo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2011;96:723–8.
5. Boaz M, Leibovitz E, Dayan YB, Wainstein J. Functional foods in the treatment of type 2 diabetes: olive leaf extract, turmeric and fenugreek, a qualitative review. Funct Foods Health Dis. 2011;1:472–81.
6. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer’s disease: an overview. Ann Indian Acad Neurol. 2008;11:13–9.
7. Ramadan G, Al-Kahtani MA, El-Sayed WM. Anti-inflammatory and antioxidant properties of Curcuma longa (turmeric) versus Zingiber officinale (ginger) rhizomes in rat adjuvant-induced arthritis. Inflammation. 2011;34:291–301.
8. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer’s disease. Curr Alzheimer Res. 2005;2:131–6.
9. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41:1955–68.
10. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78:2081–7.
11. Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010;17:190–7.
12. Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012;13:218–28.
13. Shehzad A, Lee J, Lee YS. Curcumin in various cancers. Biofactors. 2013;39:56–68.
14. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81:215S–7.
15. D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 2007;43:348–61.
16. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46:409–20.
17. Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): a hot remedy for cardiovascular disease? Int J Cardiol. 2009;131:408–9.
18. Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Altern Med. 2012;2012:516870.
19. Siddaraju MN, Dharmesh SM. Inhibition of gastric H+, K + −ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. Mol Nutr Food Res. 2007;51:324–32.
20. Wilson R, Haniadka R, Sandhya P, Palatty PL, Baliga MS. Ginger (Zingiber officinale Roscoe) the Dietary Agent in Skin Care: A Review. In: Watson RR, Zibadi S, editors. Bioactive Dietary Factors and Plant Extracts in Dermatology. Karnataska: Humana Press; 2013. p. 103–11.
21. Habib SH, Makpol S, Hamid NAA, Das S, Ngah WZ, Yusof YA. Ginger extract (Zingiber Officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63:807–13.
22. Liu Y, Whelan RJ, Pattnaik BR, Ludwig K, Subudhi E, Rowland H, et al. Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLoS One. 2012;7: e53178. doi:10.1371/journal.pone.0053178.
23. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, et al. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med. 2007;7:44.
24. Brahmbhatt M, Gundala SR, Asif G, Shamsi SA, Aneja R. Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutr Cancer. 2013;65:263–372.
25. Haniadka R, Rajeev AG, Palatty PL, Arora R, Baliga MS. Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review. J Altern Complement Med. 2012;18:440–4.
26. Pereira MM, Haniadka R, Chacko PP, Palatty PL, Baliga MS. Zingiber officinale Roscoe (ginger) as an adjuvant in cancer treatment: a review. J BUON. 2011;16:414–24.
27. Saladi RN, Persaud AN. The causes of skin cancer: a comprehensive review. Drugs Today. 2005;41:37–53.
28. Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953–2008–are recent generations at higher or lower risk? Int J Cancer. 2013;132:385–400.
29. Wang L, Shi Y, Ju P, Liu R, Yeo SP, Xia Y, et al. Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanoma. PLoS One. 2012;7:e49988.
30. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167:1124–30.
31. Santangelo C, Varì R, Scazzocchio B, Di Benedetto R, Filesi C, Masella R. Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita. 2007;43:394–405.
32. Ferrazzano G, Amato I, Ingenito A, Zarrelli A, Pinto G, Pollio A. Plant polyphenols and their anti-cariogenic properties: a review. Molecules. 2011;16:1486–507.
33. Avwioro OG, Onwuka SK, Moody JO, Agbedahunsi JM, Oduola T, Ekpo OE, et al. Curcuma longa extract as a histological dye for collagen fibres and red blood cells. J Anat. 2007;210:600–3.
34. Prathapan A, Lukhman M, Arumughan C, Sundaresan A, Raghu KG. Effect of heat treatment on curcuminoid, colour value and total polyphenols of fresh turmeric rhizome. Int J Food Sci Technol. 2009;44:1438–44.
35. Miquel J, Bernd A, Sempere JM, Díaz-Alperi J, Ramírez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr. 2002;34:37–46.
36. Ancy J, Thayumanavan B, Pournami PR. Characterization of polyphenol oxidase in ginger (Zingiber officinale R.). J Spices and Aromatic Crops. 2012;21:33–41.
37. Sasidharan S, Chen Y, Saravanan D, Sundram KM, Yoga Latha L. Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med. 2010;8:1–10.
38. Surojanametakul V, Satmalee P, Saengprakai J, Siliwan D, Wattanasiritham L. Preparation of curcuminoid powder from turmeric root (Curcuma Longa Linn) for food ingredient Use. Kasetsart J (Nat Sci). 2010;44:123–30.
39. Cirilo G, Iemma F. Antioxidant Polymers: Synthesis, Properties, and Applications. Calabria: John Wiley & Sons; 2012.
40. Wojdyło A, Oszmiański J, Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007;105:940–9.
41. Mongkolsilp S, Pongbupakit I, Sae-Lee N, Sitthihawom W. Radical scavenging activity and total phenolic content of medicinal plants used in primary health care. SWU J Pharm Sci. 2004;9:32–5.
42. Ghasemzadeh A, Jaafar HZE, Rahmat A. Antioxidant activities, total phenolics and flavonoids content in two varieties of Malaysia young ginger (Zingiber officinale Roscoe). Molecules. 2010;15:4324–33.
43. Otunola GA, Afolayan AJ. Evaluation of the polyphenolic contents and antioxidant properties of aqueous extracts of garlic, ginger, cayenne pepper and their mixture. J Applied Bot Food Qual. 2013;86:66–70.
44. Pyrzynska K, Pękal A. Application of free radical diphenylpicrylhydrazyl (DPPH) to estimate the antioxidant capacity of food samples. Anal Methods. 2013;5:4288–95.
45. Zhang W, Liu D, Wo X, Zhang Y, Jin M, Ding Z. Effects of Curcuma Longa on proliferation of cultured bovine smooth muscle cells and on expression of low density lipoprotein receptor in cells. Chin Med J. 1999;112:308–11.
46. Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ, Chang LH, et al. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 Cells. J Agric Food Chem. 2012;60:9620–30.
47. Ranjbari J, Alibakhshi A, Arezumand R, Pourhassan-Moghaddam M, Rahmati M, Zarghami N, et al. Effects of curcuma Longa extract on telomerase activity in lung and breast cancer cells. Zahedan J Res Med Sci. 2013;16:29–34.
48. Mohammad P, Nosratollah Z, Mohammad R, Abbas A, Javad R. The inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line. Afr J Biotechnol. 2010;9:912–9.
49. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985;29:197–202.
50. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κappaB-regulated gene products. Cancer Res. 2007;67:3853–61.
51. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47:293–303.
52. Chen JW, Tang YL, Liu H, Zhu ZY, Lü D, Geng N, et al. Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells. Hua Xi Kou Qiang Yi Xue Za Zhi. 2011;29:83–6.
53. Guo L, Chen XJ, Hu YH, Yu ZJ, Wang D, Liu JZ. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res. 2013;27:422–30.
54. Song F, Zhang L, Yu HX, Lu RR, Bao JD, Tan C, et al. The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells. Food Chem. 2012;132:43–50.
55. Prakobwong S, Gupta SC, Kim J., Sung B, Pinlaor P, Hiraku Y, et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis. 2011;32:1372–80.
56. Abusnina A, Keravis T, Yougbaré I, Bronner C, Lugnier C. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res. 2011;55:1677–89.
57. Zheng M, Ekmekcioglu S, Walch ET, Tang CH, Grimm EA. Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 2004;14:165–71.
58. Brown AC, Shah C, Liu J, Pham JT, Zhang JG, Jadus MR. Ginger’s (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother Res. 2009;23:640–5.
59. Chen CY, Cheng KC, Chang AY, Lin YT, Hseu YC, Wang HM. 10-shogaol, an antioxidant from zingiber officinale for skin cell proliferation and migration enhancer. Int J Mol Sci. 2012;13:1762–77.
60. Abdullah S, Abidin SAZ, Murad NA, Makpol S, Ngah WZW, Yusof YAM. Ginger extract (Zingiber officinale) triggers apoptosis and G0/G1 cells arrest in HCT 116 and HT 29 colon cancer cell lines. Afr J Biochem Res. 2010;4:134–42.
61. Choudhury D, Das A, Bhattacharya A, Chakrabarti G. Aqueous extract of ginger shows antiproliferative activity through disruption of microtubule network of cancer cells. Food Chem Toxicol. 2010;48:2872–80.
62. Leal PF, Braga ME, Sato DN, Carvalho JE, Marques MO, Meireles MA. Functional properties of spice extracts obtained via supercritical fluid extraction. J Agric Food Chem. 2003;51:2520–5.
63. Su CC, Lin JG, Li TM, Chung JC, Yang JS, Ip SW, et al. Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 2006;26:4379–89.
64. Ozaki K, Kawata Y, Amano S, Hanazawa S. Stimulatory effect of curcumin on osteoclast apoptosis. Biochem Pharmacol. 2000;59:1577–81.
65. Lin SS, Huang HP, Yang JS, Wu JY, Hsia TC, Lin CC, et al. DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett. 2008;272:77–90.
66. Huang AC, Chang CL, Yu CS, Chen PY, Yang JS, Ji BC, et al. Induction of apoptosis by curcumin in murine myelomonocytic leukemia WEHI-3 cells is mediated via endoplasmic reticulum stress and mitochondria-dependent pathways. Environ Toxicol. 2013;28:255–66.
67. Korwek Z, Bielak-Zmijewska A, Mosieniak G, Alster O, Moreno-Villanueva M, Burkle A, et al. DNA damage-independent apoptosis induced by curcumin in normal resting human T cells and leukaemic Jurkat cells. Mutagenesis. 2013;28:411–6.
68. Bush JA, Cheung Jr KJ, Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res. 2001;271:305–14.
69. Kirana C, McIntosh GH, Record IR, Jones GP. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 2003;45:218–25.
70. Harliansyah H, Murad NA, Ngah WZW, Yusof YAM. Antiproliferative, antioxidant and apoptosis effects of Zingiber officinale and 6-gingerol on HepG2 cells. Asian J Biochem. 2007;2:421–6.
71. Keum YS, Kim J, Lee KH, Park KK, Surh YJ, Lee JM, et al. Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett. 2002;177:41–7.
72. Lee E, Surh YJ. Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 1998;134:163–8.
73. Kim J. [6]-Gingerol induces apoptosis in oral cavity cancer cells. Otolaryngol Head Neck Surg. 2010;143:155–5.
74. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog. 2008;47:197–208.
75. Chakraborty D, Bishayee K, Ghosh S, Biswas R, Mandal SK, Khuda-Bukhsh AR. [6]-Gingerol induces caspase 3 dependent apoptosis and autophagy in cancer cells: drug-DNA interaction and expression of certain signal genes in HeLa cells. Eur J Pharmacol. 2012;694:20–9.
76. Huang HC, Chiu SH, Chang TM. Inhibitory effect of [6]-gingerol on melanogenesis in B16F10 melanoma cells and a possible mechanism of action. Biosci Biotechnol Biochem. 2011;75:1067–72.
77. Brand-Williams W, Cuvelier ME, Berset C. Use of free radical method to evaluate antioxidant activity. Lebensm Wiss Technol. 1995;28:25–30.